Biomarkers of Neurological Outcome After Aneurysmal Subarachnoid Hemorrhage as Early Predictors at Discharge from an Intensive Care Unit

Value of copeptin and the S-100b protein assay in ruling out the diagnosis of stroke-induced dizziness pattern in emergency departments

(2019) N. Deboevere et al.   Scandinavian Journal of Trauma Resuscitation & Emergency Medicine

Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage

(2019) Badih J. Daou et al.   CNS Neuroscience & Therapeutics

An update on diagnostic and prognostic biomarkers for traumatic brain injury

(2018) Kevin K. Wang et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Inflammatory Markers in Serum and Cerebrospinal Fluid for Early Detection of External Ventricular Drain–associated Ventriculitis in Patients With Subarachnoid Hemorrhage

(2018) Markus Lenski et al.   JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY

Neurocognitive outcomes after aneurysmal subarachnoid hemorrhage: Identifying inflammatory biomarkers

(2018) Eric Watson et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

S100B, NSE and MMP-9 fail to predict neurologic outcome while elevated S100B associates with milder initial clinical presentation after aneurysmal subarachnoid hemorrhage

(2018) Heikki Kiiski et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Stroke biomarkers in clinical practice: A critical appraisal

(2017) Geelyn J.L. Ng et al.   NEUROCHEMISTRY INTERNATIONAL

Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study

(2017) Tammam Abboud et al.   World Neurosurgery

Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage

(2016) Isabel Kellermann et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Influence of the blood-CSF-barrier function on S100B in neurodegenerative diseases

(2013) P. Steinacker et al.   ACTA NEUROLOGICA SCANDINAVICA

Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients

(2013) E.R. Zanier et al.   BRITISH JOURNAL OF ANAESTHESIA

Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: The S100B/RAGE pathway

(2012) Joan Montaner et al.   Journal of Proteomics

Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage

(2012) E. Sander Connolly et al.   STROKE

Accuracy of the S100βprotein as a marker of brain damage in traumatic brain injury

(2011) J. J. Egea-Guerrero et al.   BRAIN INJURY

S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage*

(2009) Paola Sanchez-Peña et al.   CRITICAL CARE MEDICINE

S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy

(2009) M Olivecrona et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The Prognostic Value of NSE and S100B From Serum and Cerebrospinal Fluid in Patients With Spontaneous Subarachnoid Hemorrhage

(2009) Stefan Moritz et al.   JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY

Risk factors for infections related to external ventricular drainage

(2008) D. Hoefnagel et al.   ACTA NEUROCHIRURGICA

Relationship between cerebrospinal and peripheral S100B levels after focal cerebral ischemia in rats

(2008) Yu Tanaka et al.   NEUROSCIENCE LETTERS

Overexpression of Human S100B Exacerbates Brain Damage and Periinfarct Gliosis After Permanent Focal Ischemia

(2008) Takashi Mori et al.   STROKE